ArticlePloS one2024
Can expected error costs justify testing a hypothesis at multiple alpha levels rather than searching for an elusive optimal alpha?
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simultaneous testing of one hypothesis at multiple alpha levels can be performed within a conventional Neyman-Pearson framework. This is achieved by treating the hypothesis as a family of hypotheses, each member of which explicitly concerns test level as well as effect size. Such testing encourages researchers to think about error rates and strength of evidence in both the statistical design and reporting stages of a study. Here, we show that these multi-alpha level tests can deliver acceptable expected total error costs. We first present formulas for expected error costs from single alpha and multiple alpha level tests, given prior probabilities of effect sizes that have either dichotomous or continuous distributions. Error costs are tied to decisions, with different decisions assumed for each of the potential outcomes in the multi-alpha level case. Expected total costs for tests at single and multiple alpha levels are then compared with optimal costs. This comparison highlights how sensitive optimization is to estimated error costs and to assumptions about prevalence. Testing at multiple default thresholds removes the need to formally identify decisions, or to model costs and prevalence as required in optimization approaches. Although total expected error costs with this approach will not be optimal, our results suggest they may be lower, on average, than when "optimal" test levels are based on mis-specified models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.